NCT01265225撤回不适用
Prognostic Value of Stem Cell Related Markers CD24, CD44, CD326 and EPCR, for Predicting Breast Cancer Recurrence in Tumor Stages 0-II
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
研究概览
简要总结
The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Ductal Carcinoma in Situ
- •DCIS + Microinvasion stages 1 or 11 without positive lymph nodes
排除标准
- •tumor specimen with higher than grade II
- •BRACA 1 or BRACA 2 mutation
- •Neoadjuvant chemotherapy
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Prognostic Biomarker for CRCColorectal CancerNCT03928652Sixth Affiliated Hospital, Sun Yat-sen University1,050
已完成
不适用
Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary SyndromesAcute Coronary SyndromesNCT02117037Assistance Publique Hopitaux De Marseille180
Unknown
不适用
The Prospective Risk Factor Evaluation & Discovery In CTEPH StudyChronic Thromboembolic Pulmonary HypertensionNCT03470207Mark W. Dodson130
已完成
不适用
A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic HeadachePost-Traumatic HeadacheHealthyNCT06132529Mayo Clinic151
已完成
不适用
Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee OsteoarthritisKnee OsteoarthritisNCT02070224Artialis120